Related by context. All words. (Click for frequent words.) 79 NGX# 74 INCB# [001] 73 oral prodrug 73 adipiplon 73 cannabinor 72 tezampanel NGX# 72 R#/MEM # 71 alvimopan 71 Phase Ib study 71 diabetic neuropathic pain 71 CCX# 71 Traficet EN 70 Panzem R NCD 70 PRT# 70 Panzem R 70 Phenoptin 70 pseudobulbar affect PBA 70 OMNARIS HFA 70 PRX # 70 phase IIa clinical 70 bicifadine 70 ALGRX 70 Zenvia ™ 70 BEMA TM Fentanyl 69 SILENOR TM 69 Vilazodone 69 MAP# 69 PDE4 inhibitor 69 selective androgen receptor modulator 69 RSD# 69 Icatibant 69 forodesine 69 PXD# 69 Synavive 69 ganetespib 69 BEMA Buprenorphine 69 Bicifadine 69 SARMs 69 KRN# 69 KNS # 69 Pimavanserin 69 vilazodone 69 favorable pharmacokinetic profile 69 Elagolix 69 torezolid phosphate 69 Relivar 69 Neurodex 69 XmAb# 68 Tyrima 68 HuLuc# 68 MAGE A3 ASCI 68 eltrombopag 68 Arikace 68 Ophena TM 68 MGCD# [001] 68 alvespimycin 68 otelixizumab 68 Sym# 68 tanespimycin 68 Archexin 68 Corlux 68 JAK inhibitor 68 Azedra 68 Golimumab 68 Serdaxin 68 Zoraxel 68 Stedivaze 68 Milnacipran 68 ularitide 68 SILENOR 68 intranasal formulation 68 Gabapentin GR 68 atacicept 68 TOLAMBA 68 Trofex 68 MoxDuo IR 68 class mGluR5 inhibitor 68 evaluating tivozanib 68 Civacir 68 ponatinib 68 NVA# 68 RGB # 68 Octreolin 68 CCR9 antagonist 67 TriRima 67 rNAPc2 67 Azedra TM 67 vidofludimus 67 BEMA TM LA 67 Mipomersen 67 incyclinide 67 tiapamil 67 CORT # 67 CR# vcMMAE 67 AEG# 67 LEP ETU 67 ARIKACE ™ 67 Tezampanel 67 lesinurad 67 dextromethorphan quinidine 67 MoxDuo 67 BAY #-# 67 Menerba 67 TELINTRA 67 tasocitinib 67 Phase 2a trial 67 teriflunomide 67 INT# [002] 67 visilizumab 67 PHX# 67 ulimorelin 67 Zelrix 67 opioid induced bowel dysfunction 67 Symadex 67 peripherally acting 67 VAPRISOL 67 aplindore 67 HGS ETR1 67 DDP# 67 TG# [003] 67 HuMax CD# 67 metaglidasen 67 Ceflatonin 67 LEVADEX TM 67 OncoVEX GM CSF 67 dexanabinol 67 OXi# 67 NP2 Enkephalin 67 velafermin 67 GALNS 67 PEG SN# 67 Tasimelteon 67 LUVENIQ 67 Clonicel 67 docetaxel Taxotere ® 66 ProSavin 66 Nasulin 66 ELND# 66 HGS# 66 HGS ETR2 66 EP #R 66 PEG PAL 66 sapacitabine 66 Zingo TM 66 PSN# [002] 66 vascular disrupting agent 66 GAMMAGARD 66 Linjeta TM 66 lomitapide 66 LEVADEX 66 anticancer compound 66 ICA # 66 Anavex #-# 66 Exelixis compounds 66 Proquin XR 66 FROVA 66 cystinosis patients 66 AeroLEF TM 66 HCV protease inhibitor 66 ABILIFY ® 66 long acting muscarinic 66 tecarfarin 66 initiate Phase 1b 66 INCB# [002] 66 EOquin 66 ALN PCS 66 TBC# 66 Xanafide 66 ZOLINZA 66 investigational humanized monoclonal antibody 66 preclinically 66 ASONEP 66 Tesetaxel 66 inhaled formulation 66 oral formulation 66 BNC# 66 Nebido 66 treprostinil 66 phase IIb trial 66 ospemifene 66 oral picoplatin 66 LY# [003] 66 Panzem 66 EndoTAG TM -1 66 tafamidis 66 Zerenex 66 YONDELIS 66 oral rivaroxaban 66 octreotide acetate 66 mGluR5 NAM 66 cMET 66 Anturol TM 66 GRN# 66 ruxolitinib 66 investigational monoclonal antibody 66 ENMD # 66 Cloretazine ® 66 AzaSite Plus 66 lintuzumab 66 oxymorphone ER 66 PRTX 66 orally bioavailable 66 eprotirome 66 phase IIb clinical 66 teduglutide 66 eniluracil 66 Omacetaxine 66 zileuton 66 PLK1 SNALP 66 mGluR5 negative 66 HuMax EGFr 66 Ketotransdel TM 66 Excellarate 66 faropenem 66 OMS#HP 66 methylnaltrexone 66 AP# [003] 66 TOCOSOL Paclitaxel 65 CB2 selective receptor agonist 65 Capesaris 65 PSN# [001] 65 Factor VIIa 65 elotuzumab 65 iSONEP 65 Alzhemed TM 65 RAPAFLO 65 obatoclax 65 pomalidomide 65 riociguat 65 Trofex TM 65 Personalized Immunotherapy 65 RhuDex ® 65 rHuPH# 65 noninfectious uveitis 65 XP# XP# 65 ONCONASE R 65 mertansine 65 HuMax CD4 65 OvaRex R 65 deforolimus 65 Naproxcinod 65 Dyloject TM 65 PD LID 65 Frova ® 65 Plicera 65 CRx 65 proteasome inhibitor 65 pertuzumab 65 antiplatelet agent 65 MEK inhibitors 65 Phase 1b trial 65 Iloperidone 65 Amplimexon 65 CEQ# 65 novel oral anticoagulant 65 omega interferon 65 Solazed TM 65 efficacy tolerability 65 IL# PE#QQR 65 Anturol 65 ostarine 65 Aurexis 65 SinuNase 65 MyVax R 65 elagolix 65 JAK2 inhibitor 65 EXPAREL TM 65 SNRI 65 ISIS # 65 Phase IIb trials 65 IMA# 65 Elesclomol 65 Adlea 65 Phase IIb clinical trials 65 serotonin norepinephrine reuptake inhibitor 65 mGluR2 positive 65 leading oral taxane 65 tasimelteon 65 Serdaxin ® 65 calcineurin inhibitors 65 Dextofisopam 65 investigational therapies 65 orally administered inhibitor 65 Cetrorelix 65 #ME# 65 sitaxsentan 65 Solzira 65 NasalFent 65 Cethrin 65 desvenlafaxine 65 radiation sensitizer 65 Nanobody 65 R#/MEM 65 generation purine nucleoside 65 Phase 2a 65 severe gastroparesis 65 lurasidone 65 DuraSite 65 Hsp# inhibition 65 EZN 65 Androxal TM 65 ALVESCO HFA 65 UPLYSO 65 epothilone 65 uric acid lowering 65 TACI Ig 65 Soliris eculizumab 65 talactoferrin 65 Inhalation Solution 65 Elotuzumab 65 Genz # 65 OncoVEX 65 Interferon alpha 65 OMNARIS Nasal Spray 65 huC# DM4 65 enzastaurin 65 Dasatinib 65 Oral NKTR 65 Perifosine 65 TRIOLEX 65 targeted radiotherapeutic 65 reslizumab 65 Chemophase 65 Lamictal ODT 65 Pafuramidine 65 Allovectin 7 R 65 RLY# 65 Virulizin ® 65 ATL# [001] 65 Perforomist ™ Inhalation Solution 65 LymphoStat B TM 65 Phase IIa trial 65 tocilizumab 65 Voreloxin 65 IV APAP 65 Seliciclib 65 docetaxel Taxotere R 65 Carfilzomib 65 Guanilib 65 LibiGel ® 65 Cardio Vascu Grow 65 dextofisopam 65 Nexavar ® 65 ALN TTR# 65 Pivotal Phase III 65 Cannabinor 65 pan HDAC inhibitor 64 PolyActive ® 64 subcutaneous formulation 64 IAP inhibitors 64 MNTX 64 Dalbavancin 64 Preclinical studies suggest 64 CA4P 64 Nanobody ® 64 TPI ASM8 64 HCD# [002] 64 Phase 1a clinical 64 Cleviprex TM clevidipine 64 GAP #B# 64 Microplasmin 64 oral taxane 64 ATPace 64 pralatrexate 64 AZILECT R 64 TRANSDUR Sufentanil 64 Ereska 64 ixabepilone 64 PNP inhibitor 64 anidulafungin 64 topical NSAID 64 alefacept 64 Amigal 64 Bortezomib 64 M6G 64 Romidepsin 64 SNT MC# 64 immunomodulatory therapy 64 Sapacitabine 64 nucleoside analog 64 Meets Primary Endpoint 64 NUVIGIL 64 RECOTHROM R 64 pegylated interferons 64 avanafil 64 hormone LHRH antagonist 64 BRAF inhibitor 64 Nasulin ™ 64 MEK inhibitor 64 oral salmon calcitonin 64 registrational 64 CBLC# 64 6R BH4 64 Indaflex TM 64 GSK# [001] 64 CIMZIA TM 64 somatostatin analogue 64 linaclotide 64 Fibrin Pad 64 vascular disrupting agents 64 Zenvia TM 64 Octreotide 64 Lu AA# 64 TOCOSOL Camptothecin 64 CoFactor 64 SAR# [002] 64 intravenous acetaminophen 64 RSD# oral 64 Phase III Clinical Trial 64 delivers fluocinolone acetonide FA 64 fosbretabulin 64 IMC A# 64 NEUGENE 64 baminercept 64 ORE# 64 DexaSite 64 pharmacodynamic properties 64 Cloretazine R VNP#M 64 liposomal formulation 64 Ambrisentan 64 HCV protease inhibitors 64 Methylnaltrexone 64 systemically administered 64 ALD# 64 ALN VSP 64 Tekamlo 64 candidate XP# 64 NNR Therapeutics 64 FM VP4 64 Phase #b/#a trial 64 VA# [002] 64 TRV# [001] 64 Bezielle 64 Rebif ® 64 Fibrillex TM 64 Alfimeprase 64 DU #b 64 oral ridaforolimus 64 hepatitis C protease inhibitor 64 ACV1 64 Linaclotide 64 AZILECT ® 64 Phase III Pivotal 64 TAFA# 64 PI3K/Akt pathway inhibitor 64 Entereg R 64 liprotamase 64 refractory gout 64 ZYBRESTAT 64 Tolvaptan 64 anticancer agent 64 Cellegesic 64 MEK inhibitor RDEA# 64 dacetuzumab 64 Tarvacin TM 64 Firazyr 64 GLYX 64 Q#IR 64 LymphoStat B 64 APOPTONE 64 ELADUR 64 mapatumumab 64 Phase IIB 64 SERMs 64 ATL# [002] 64 Spiegelmer ® 64 entinostat 64 schizophrenia CIAS 64 Viprinex 64 investigational pan BCR 64 postoperative ileus 64 ALN TTR 64 Targretin 64 Leukine 64 PS# [001] 64 DCCR 64 FOLOTYN ® 64 selective modulator 64 dyskinesia PD LID 64 Excellarate TM 64 ADX# 64 Zenvia 64 CorVue ™ 64 CINTREDEKIN BESUDOTOX 64 adecatumumab 64 GLPG# 64 safinamide 64 analgesic efficacy 64 Ketotransdel 64 nicotinic alpha 7 64 LHRH antagonists 64 phase IIa 64 zileuton CR 64 DR Cysteamine 64 axitinib 64 Talabostat 64 CCX# B 64 anti amnesic 64 GMX# 64 HCV protease 64 thrombolytic agent 64 CDP# 64 Phase III confirmatory 64 ganaxolone 64 Aflibercept 63 ocular formulation 63 Laquinimod 63 BRIM2 63 vosaroxin 63 Triolex 63 regorafenib 63 EMBEDA ™ 63 Proxinium TM 63 confirmatory Phase III 63 Phase #b/#a 63 erlotinib Tarceva ® 63 SLx 63 Tarceva TM 63 allosteric modulator NAM 63 Prodarsan ® 63 acyclovir Lauriad R 63 Bendavia 63 GATTEX ™ 63 Revimmune 63 ATL/TV# 63 sufentanil 63 MoxDuo TM IR 63 REOLYSIN ® 63 Unit Dose Budesonide 63 Darusentan 63 Vaprisol 63 CCR5 mAb 63 JAK Inhibitor 63 protein kinase inhibitor 63 SCH # 63 EpiCept NP 1 63 odanacatib 63 Silodosin 63 markets Gelclair R 63 endothelin receptor antagonists 63 carbidopa levodopa 63 Zileuton 63 REG1 63 sulodexide 63 Allovectin 7 ® 63 EXPAREL 63 OMP #M# 63 lapatinib Tykerb 63 Azixa 63 Aclidinium 63 ALKS 63 opioid analgesic 63 lumiliximab 63 Valdoxan 63 pradefovir 63 PTH1 63 CYT# potent vascular disrupting 63 Sanctura XR 63 oral FTY# 63 successfully commercialize Iluvien 63 DXL# 63 sorafenib tablets 63 OMAPRO 63 virus HCV protease inhibitor 63 Ventavis 63 Durezol 63 CRLX# 63 rxRNA 63 placebo controlled clinical 63 Probuphine 63 systemic RNAi therapeutic 63 herpetic keratitis 63 oral anticoagulant 63 LEVADEX ™ 63 Soliris TM eculizumab 63 MERLIN TIMI 63 Resten NG 63 receptor tyrosine kinase inhibitor 63 Zemiva TM 63 vorinostat 63 Surfaxin LS 63 maximally tolerated dose 63 ACUROX ® 63 Factor Xa inhibitor 63 EFAPROXYN 63 FENTORA 63 PrevOnco 63 tamibarotene 63 BRINAVESS 63 PDE4 inhibitors 63 postoperative ileus POI 63 OHR/AVR# 63 Iluvien ® 63 Belimumab 63 XL# anticancer compounds 63 S/GSK# 63 PLX cells 63 Aloxi R 63 2 methoxyestradiol 63 PROMACTA 63 muraglitazar 63 cetrorelix 63 histone deacetylase HDAC inhibitor 63 AAG geldanamycin analog 63 Reverset 63 Marqibo 63 angiogenesis inhibitor 63 DP b# 63 PEG Interferon lambda 63 Asentar 63 dexpramipexole 63 laquinimod 63 polymerase inhibitor 63 LHRH antagonist 63 ACAPODENE 63 BENLYSTA ® 63 DAVANAT 63 T Pred 63 Phase 2a clinical 63 Cimzia R 63 dimebon latrepirdine 63 albiglutide 63 brivaracetam 63 Valortim 63 ARIKACE 63 Zoraxel TM 63 SAPHRIS 63 biologic therapy 63 BLA filing 63 INTEGRILIN 63 SRT# [003] 63 Gel repository corticotropin injection 63 acetonide FA 63 phase 2a 63 anti emetic therapy 63 Angiocept 63 Phase III Clinical Trials 63 BYETTA ® 63 GLP1 agonist 63 imexon 63 apremilast 63 Intermezzo R 63 Fx #A 63 LymphoStat B belimumab 63 BrachySil 63 apomorphine 63 highly selective inhibitor 63 Troxatyl 63 QVA# 63 therapeutic monoclonal antibody 63 anticoagulant reversing agent 63 Lacosamide 63 urocortin 2 63 cediranib 63 cariprazine 63 thymalfasin 63 Chrysalin 63 esophageal candidiasis 63 Ceflatonin R 63 glucagon receptor 63 Degarelix 63 Phase IIa clinical 63 voreloxin 63 candidate deforolimus 63 Dapagliflozin 63 romidepsin 63 small molecule defensin 63 sorafenib Nexavar 63 JAK inhibitors 63 adenosine injection 63 CIP TRAMADOL ER 63 Phase 2a Clinical Trial 63 CDK inhibitor 63 PROVENGE sipuleucel T 63 Phase 2a clinical trials 63 Phase IIa trials 63 Ventavis ® 63 IAP inhibitor 63 tiotropium bromide 63 IMC #B 63 CTAP# Capsules 63 Technosphere Insulin 63 Oracea TM 63 perampanel 63 Arcalyst 63 aldehyde dehydrogenase ALDH2 deficiency 63 Alocrest 63 rhIGF-I/rhIGFBP-3 63 XL# XL# 63 relapsing remitting multiple sclerosis 63 radezolid 63 Cytolin R 63 JAK1 63 rasagiline tablets 63 Lixivaptan 63 Omnitarg 63 trodusquemine 63 ISTODAX 63 AQ4N 63 MDV# 63 CYC# 63 catheter occlusion 63 QNEXA 63 pharmacokinetic interactions 63 TYZEKA 63 ONTAK 63 novel VDA molecule 63 PhosLo 63 USL# 63 Desmoteplase 63 rifalazil 63 Zalbin 62 AMEVIVE 62 BEMA Fentanyl 62 Amphotericin B 62 TREANDA 62 EVIZON 62 neurogenic orthostatic hypotension 62 allosteric modulator PAM 62 IPLEX 62 bendamustine 62 forodesine hydrochloride 62 Targretin capsules 62 KIACTA ™ 62 CG# [003] 62 ThGRF 62 delafloxacin 62 cangrelor 62 CINQUIL 62 5 HT3 antagonist 62 febuxostat 62 Ridaforolimus 62 tizanidine hydrochloride short 62 ramelteon 62 acute migraine 62 ALVESCO R 62 EXALGO 62 PEGylated Fab fragment 62 veltuzumab 62 telcagepant 62 Azedra ™ 62 Plenaxis TM 62 oral transmucosal 62 CCR5 antagonist 62 blinded randomized placebo controlled 62 Protexia R 62 zileuton IV 62 IPX# 62 overactive bladder AA# 62 alfimeprase 62 Phase 2b clinical trials 62 mirtazapine 62 Tamibarotene 62 compound INCB# 62 synthetic retinoid 62 talabostat 62 Zybrestat 62 ONCONASE 62 Phase Ib 62 PDX pralatrexate 62 Fodosine 62 Somatuline Depot 62 GSK# [002] 62 CYCLOSET 62 INCB# [003] 62 CIMZIA ™ 62 alagebrium 62 AVE# 62 Hsp# Inhibitor 62 CRMD# 62 Combidex 62 Ocrelizumab 62 Levetiracetam 62 Restanza 62 GED aPC 62 MOZOBIL 62 MGd 62 BCR ABL inhibitor 62 ENTEREG ® 62 luteinizing hormone releasing 62 sunitinib malate 62 triphendiol 62 generation Hsp# inhibitor 62 SinuNase ™ 62 Adalimumab 62 Viramidine 62 phase Ib 62 SILENOR ™ 62 ropinirole Requip 62 INTELLITAB TM 62 VEGF inhibitors 62 ATryn R 62 Forodesine HCl 62 LY# [002] 62 ATPace TM 62 clonidine hydrochloride 62 Perforomist TM Inhalation Solution 62 ozarelix 62 MKC# MKC# PP 62 Phase IIa 62 BCR ABL inhibitors 62 XL# XL# XL# 62 Deforolimus 62 Locteron ® 62 RG# [001] 62 MYDICAR ® 62 paliperidone palmitate 62 OncoGel 62 Exenatide LAR 62 gabapentin enacarbil 62 volociximab 62 Phase 2b Clinical Trial 62 MAXY G# 62 XmAb 62 TYKERB 62 novel histone deacetylase 62 Adentri 62 Neuradiab 62 Excellagen 62 IPL# 62 diarrhea predominant irritable 62 nalbuphine ER 62 MAXY alpha 62 Zipsor 62 ibudilast 62 ILUVIEN ® 62 Phase 2b study 62 HGS ETR1 mapatumumab 62 PDE# inhibitors 62 TH# [003] 62 PKC# 62 motexafin gadolinium Injection 62 rufinamide 62 bazedoxifene 62 SAR# [004] 62 molecular imaging radiopharmaceutical 62 Prosaptide 62 sumatriptan DosePro 62 Clolar ® 62 Anticalins 62 Aegerion 62 DepoDur 62 AEGR 62 Locteron 62 FOLFOX6 chemotherapy regimen 62 Nuvion 62 Aliskiren 62 HQK 62 topiramate Topamax 62 valopicitabine 62 Epothilones 62 dirucotide 62 Pivotal Phase 62 Cethromycin 62 AZD# 62 TNF alpha inhibitor 62 multi kinase inhibitor 62 velafermin belinostat 62 selective estrogen receptor modulator 62 Cand5 62 subcutaneously administered 62 TKM ApoB 62 novel prodrug 62 glatiramer 62 faropenem medoxomil 62 decitabine 62 zanolimumab 62 Vernakalant 62 lanreotide 62 Novolimus 62 SinuNase TM 62 OSMOPREP 62 OMS# 62 developing Bicifadine serotonin 62 THR beta agonist 62 Pagoclone 62 clevidipine 62 JZP 62 neuroprotective properties 62 RAPTIVA 62 ONSOLIS 62 registrational trial 62 flupirtine 62 EGFR inhibitors 62 CIPN 62 Acetavance 62 APF# 62 NPSP# 62 Imprime PGG 62 alemtuzumab Campath 62 corticotropin injection 62 TLK# 62 BEMA Granisetron 62 midstage clinical 62 Ostabolin C 62 oxypurinol 62 Levadex 62 asenapine 62 Intravail ® 62 either acutely decompensated 62 glucokinase activator 62 quetiapine fumarate 62 Pathway Inhibitor 62 rilonacept 62 Pralatrexate 62 OvaRex ® MAb 62 ATryn ® 62 CGEN # 62 Dual Opioid 62 Combo Stent 62 EOquin TM 62 Besivance 62 candidate Zenvia 62 Generx 62 Cerimon 62 BCX# 62 Anticalin 62 trospium 62 Xcytrin R 62 GGF2 62 hyaluronidase enzyme 62 Eltrombopag 62 phase IIb 62 Aganocide 62 refractory Hodgkin lymphoma 62 HZT 62 Squalamine 62 ZYBRESTAT fosbretabulin 62 lixivaptan 62 intranasal insulin product 62 Phase #b/#a clinical 62 Ophena 62 unique alkylating agent 62 delta opioid receptor 62 including eniluracil ADH 62 Onco TCS 62 OZURDEX ® 62 injectable formulations 62 transdermal spray 62 neratinib 62 Pertuzumab 62 double blinded placebo 62 Zenvia Phase III 62 TRAIL receptor antibodies 62 ambrisentan 62 betrixaban 62 E2F Decoy 62 antiangiogenic agents 62 XYOTAX TM 62 Solulin 62 injectable formulation 62 ALN HTT 62 NovaBay Aganocide compounds 62 Azilect ® 62 hoFH 62 Lodotra 62 indacaterol 62 BENLYSTA TM 62 Debio 62 Maribavir 62 drug ISA# 62 Indibulin 62 investigational compound 62 Safinamide 62 p# inhibitor 62 Phase IIIb clinical 62 ZEGERID Capsules 62 oral antiviral 62 Lamotrigine 62 NMDA antagonist 62 vemurafenib 62 ESBA# 62 Xerecept 62 Exelixis XL# 62 Cethrin R 62 LAF# 62 Radezolid 62 histamine dihydrochloride 62 DepoBupivacaine TM 62 Aryplase 62 Telaprevir 62 beta 1a 62 TNF Tumor Necrosis Factor 62 selective adenosine 62 LEUKINE 62 cancer immunotherapies 62 Bafetinib 62 DOS# 62 active comparator 62 immunomodulatory 62 gepirone ER 62 BAL# [002] 62 injectable investigational 62 Initiates Phase III 62 SPRIX ® 62 R roscovitine 62 ELACYT 62 Epanova 62 sd rxRNA